Villancencio, Dennis B.
HRN: 22-40-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2023
CEFTRIAXONE 1G (VIAL)
01/02/2023
01/09/2023
IVT
2g
OD
Complete Bowel Obstruction Sec To Colonic Mass (adenocarcinoma)
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes